Navigation Links
Cell Therapeutics, Inc.'s (CTI) Presentation at BioCentury NewsMakers Conference to be Webcast
Date:9/15/2009

SEATTLE, Sept. 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at BioCentury's NewsMakers in the Biotech Industry conference on Wednesday, September 16, 2009, at 10:30 AM Eastern.

The conference will be held September 16, 2009, at the Millennium Broadway Hotel in New York.

The conference will be webcast live with slides and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.

           BioCentury's NewsMakers in the Biotech Industry Conference
                 CTI Presentation: Wednesday, September 16, 2009
        10:30 a.m. Eastern /7:30 a.m. Pacific /6:30 p.m. Central European
              Audio webcast with slides at www.celltherapeutics.com




    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: media@ctiseattle.com
    www.celltherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
2. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
7. Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
8. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
9. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
10. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
11. Cell Therapeutics, Inc. Announces $6.5 Million Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... According to the new research report "Isocyanate ... & Forecast to 2019" defines and segments the ... the market value. The isocyanate material market value ... a significant CAGR from 2014 to 2019. , ... spread through 286 pages and in-depth TOC on ...
(Date:8/22/2014)... the leading pan-European organisation representing medical oncology professionals, ... receiving the Society,s esteemed annual awards. The awards ... and Peter Boyle on the occasion of the ... Carsten Bokemeyer will receive the ESMO Award for ... discovery into real benefit at patient level. 1 ...
(Date:8/22/2014)... 2014 The report "Higher Education ... & Compliance, Campus Technology, Student & Curriculum, Performance ... defines and segments the global Higher Ed market ... forecasting of market sizes. The report also identifies ... opportunities impacting it along with the adoption trends. ...
(Date:8/22/2014)... 2014 A new study finds a wide range ... be related to key environmental exposuresin children with Crohn,s disease ... journal of the Crohn,s & Colitis Foundation of America ... Williams & Wilkins , a part of Wolters Kluwer ... of alterations of DNA in several regions of the genome ...
(Date:8/22/2014)... of Alzheimer,s disease can be slowed and some ... that is found in pomegranate. Also, the ... arthritis and Parkinson,s disease could be reduced, according ... by University of Huddersfield scientist Dr Olumayokun Olajide, ... products. , Now, a new phase of research ...
Breaking Medicine News(10 mins):Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2
... In a new reflection on the dangers currently gripping humanity, ... to invest in public health and not arms. ... any noble heart, said Castro in his recent article broadcast ... feature, Castro condemned the construction of a "wonderful submarine" in ...
... far better than drinking water, researchers said. ,There ... cups of tea can reduce the risk of heart attacks. ... King's College London, it is a wrong belief that tea ... as it contains antioxidants. It does not dehydrate you, Mirror ...
... a new outbreak of avian flu at three poultry farms ... ,Laboratory tests confirmed the presence of H5N1, a ... three farms in Chak Shehzad, where about 12,000 birds died ... and Livestock Ministry. ,There were no reports of ...
... combination asthma therapy, SYMBICORT leads to significant improvements ... patient-reported satisfaction with asthma treatment, versus its ... ,SYMBICORT is a recently approved, combination therapy indicated ... patients 12 years of age and older. SYMBICORT ...
... comprehensive survey carried out by the World Conservation Union (IUCN) ... threatened with extinction. ,Unless the trend is ... able to meet its self-imposed target of halting biodiversity loss ... that live in Europe and western Russia, some 15 percent ...
... at Arizona State University has used molecular biology tricks to ... with the ones that occurred naturally. ... new proteins in a fraction of the three billion years ... led to some surprisingly new lessons on how to optimize ...
Cached Medicine News:Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:One-sixth of Europe's Mammals Face Extinction, Warns Conservation Experts 2
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... third international medical cannabis conference taking place at ... France , on October 22, 2014.  The ... stakeholders, such as researchers, health professionals, and patients, ...
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - SQI ... that develops and commercializes proprietary technologies and products ... has entered into a Master Service Agreement to ... DNA-based pathogen detection assays. During the initial phase ... deliver an automated working prototype of one of ...
(Date:8/21/2014)... Conn. , Aug. 21, 2014  Aptuit ... West Lafayette, Indiana , has enhanced ... and characterization of small and large molecules, including ... of the Bruker maXisPlus Q-TOF mass spectrometer. ... Goldman , CEO, Aptuit, said, "The expanded large ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2
... 6 TargeGen, Inc. today announced that,the Company,s ... and the,Company plans to initiate a multi-center clinical ... highly selective JAK2 inhibitor in,January, 2008. Additionally, TargeGen ... will be made at the 2007 ASH Conference,(Atlanta, ...
... Inc. (Nasdaq: BCRX ) today provided an ... Forodesine HCl Data to be Presented at American ... Chair, Dermatology, The University of,Texas M.D. Anderson Cancer ... Phase I/II clinical study of oral forodesine HCl ...
Cached Medicine Technology:TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH 2BioCryst Provides Forodesine HCl Update 2BioCryst Provides Forodesine HCl Update 3BioCryst Provides Forodesine HCl Update 4BioCryst Provides Forodesine HCl Update 5
55 DSL's new collection of optical frames has established a strong personality and developed,superficial retro concepts with contemporary styles and strong impacting colours....
... and highly sought-after, the ... collection of sunglasses and ... the very latest men's ... timeless sources of inspiration ...
... Extended Ablation laser enables the physician to provide ... results and no downtime., The new Whisper NG ... an extra long pulse width to achieve "Extended ... over 3-5 days, and occurs simultaneously with the ...
... the art software package designed to assist in ... by a lens manufacturer with years of experience ... is designed to help you run your lab ... the software dictates., ,Designed specifically for integrated retail ...
Medicine Products: